SKI 1695
Alternative Names: NSC D665585Latest Information Update: 04 Jun 1998
At a glance
- Originator SK Pharma
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 04 Jun 1998 Discontinued-Preclinical for HIV-1 infections in South Korea (Unknown route)
- 05 Jan 1995 Preclinical development for HIV-1 infections in South Korea (Unknown route)